pociredir   Click here for help

GtoPdb Ligand ID: 11523

Synonyms: Example 90 [WO2020190754] | FTX-6058 | FTX6058
Compound class: Synthetic organic
Comment: FTX-6058 binds to embryonic ectoderm development (EED) and induces foetal haemoglobin (HbF) tetramer production via modulation of PRC2. It was developed by Fulcrum Therapeutics as an oral drug for the treatment of sickle cell disease or beta thalassemia. We matched the chemical structure for the INN 'pociredir' (from the WHO's proposed INN list 127, July 2022) to the structure for FTX-6058.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 73.57
Molecular weight 403.14
XLogP 5.74
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1ncccc1c1cc2OC[C@H]3COc4c3c(CNc2n2c1nnc2)c(F)cc4
Isomeric SMILES Cc1ncccc1c1cc2OC[C@H]3COc4c3c(CNc2n2c1nnc2)c(F)cc4
InChI InChI=1S/C22H18FN5O2/c1-12-14(3-2-6-24-12)15-7-19-22(28-11-26-27-21(15)28)25-8-16-17(23)4-5-18-20(16)13(9-29-18)10-30-19/h2-7,11,13,25H,8-10H2,1H3/t13-/m1/s1
InChI Key JQBUTSBIFNKJMW-CYBMUJFWSA-N
References
1. Efremov IV, Kazmirski S, Li q, Thompson LA III, Wallace OW, Johnstone SD, Zhou F, Rahl P. (2020)
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS.
Patent number: WO2020190754. Assignee: FULCRUM THERAPEUTICS, INC. Priority date: 15/03/2019. Publication date: 24/09/2020.